BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12397580)

  • 1. The metabolic demands of driving for drivers with type 1 diabetes mellitus.
    Cox DJ; Gonder-Frederick LA; Kovatchev BP; Clarke WL
    Diabetes Metab Res Rev; 2002; 18(5):381-5. PubMed ID: 12397580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sex on counterregulatory responses to exercise after antecedent hypoglycemia in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Morrey S; Wasserman DH; Davis SN
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E16-24. PubMed ID: 14998785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus.
    Admon G; Weinstein Y; Falk B; Weintrob N; Benzaquen H; Ofan R; Fayman G; Zigel L; Constantini N; Phillip M
    Pediatrics; 2005 Sep; 116(3):e348-55. PubMed ID: 16140677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonwarning hypoglycemia in drivers with diabetes.
    Haunz EA; Brosseau JD
    Am Fam Physician; 1984 Oct; 30(4):189-97. PubMed ID: 6388291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus.
    Sandoval DA; Guy DL; Richardson MA; Ertl AC; Davis SN
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1331-8. PubMed ID: 16449302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes.
    Galassetti P; Tate D; Neill RA; Richardson A; Leu SY; Davis SN
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1109-17. PubMed ID: 16403779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein and glutamine kinetics during counter-regulatory failure in type 1 diabetes.
    Battezzati A; Benedini S; Sereni LP; DeTaddeo F; Maffi P; Secchi A; Luzi L
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):352-7. PubMed ID: 18693094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes.
    Aftab Guy D; Sandoval D; Richardson MA; Tate D; Davis SN
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E258-65. PubMed ID: 15784645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decision not to drive during hypoglycemia in patients with type 1 and type 2 diabetes according to hypoglycemia awareness.
    Stork AD; van Haeften TW; Veneman TF
    Diabetes Care; 2007 Nov; 30(11):2822-6. PubMed ID: 17686831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-treatment of hypoglycemia while driving.
    Cox DJ; Gonder-Frederick LA; Kovatchev BP; Clarke WL
    Diabetes Res Clin Pract; 2001 Oct; 54(1):17-26. PubMed ID: 11532326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetic drivers with and without a history of recurrent hypoglycemia-related driving mishaps: physiological and performance differences during euglycemia and the induction of hypoglycemia.
    Cox DJ; Kovatchev BP; Anderson SM; Clarke WL; Gonder-Frederick LA
    Diabetes Care; 2010 Nov; 33(11):2430-5. PubMed ID: 20699432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving mishaps and hypoglycaemia: risk and prevention.
    Cox D; Clarke W; Gonder-Frederick L; Kovatchev B
    Int J Clin Pract Suppl; 2001 Sep; (123):38-42. PubMed ID: 11594297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2 weeks of theophylline on glucose counterregulation in patients with type 1 diabetes and unawareness of hypoglycemia.
    de Galan BE; Tack CJ; Lenders JW; Lutterman JA; Smits P
    Clin Pharmacol Ther; 2003 Jul; 74(1):77-84. PubMed ID: 12844138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
    Bevier WC; Zisser H; Palerm CC; Finan DA; Seborg DE; Doyle FJ; Wollitzer AO; Jovanovic L
    Diabetes Metab Res Rev; 2007 Sep; 23(6):472-8. PubMed ID: 17315240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute hypoglycemia on motivation and cognitive interference in people with type 1 diabetes.
    McAulay V; Deary IJ; Sommerfield AJ; Matthews G; Frier BM
    J Clin Psychopharmacol; 2006 Apr; 26(2):143-51. PubMed ID: 16633142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.